Nile tilapia Toll-like receptor 7 subfamily: Intracellular TLRs that recruit MyD88 as an adaptor and activate the NF-κB pathway in the immune response-Reference-Cited by-同舟云学术

Nile tilapia Toll-like receptor 7 subfamily: Intracellular TLRs that recruit MyD88 as an adaptor and activate the NF-κB pathway in the immune response

Published:2021-12 Issue: Volume:125 Page:104173
ISSN:0145-305X
Container-title:Developmental & Comparative Immunology
language:en
Short-container-title:Developmental & Comparative Immunology

Author:

Gao Fengying,Liu Jie,Lu Maixin,Liu Zhigang,Wang Miao,Ke Xiaoli,Yi Mengmeng,Cao Jianmeng

Publisher

Elsevier BV

Subject

Developmental Biology,Immunology

Reference61 articles.

1. Toll-like receptor signaling;Akira;J. Biol. Chem.,2003

2. Pathogen recognition and innate immunity;Akira;Cell,2006

3. Identification and expression analysis of cobia (Rachycentron canadum) Toll-like receptor 9 gene;Byadgi;Fish Shellfish Immunol.,2014

4. TLR8: the forgotten relative revindicated;Cervantes;Cell. Mol. Immunol.,2012

5. Non-specific defence mechanisms in fish, with particular reference to the reticuloendothelial system (RES);Dalmo;J. Fish. Dis.,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventive and reparative potentials of heat-inactivated and viable commensal Bacillus pumilus SE5 in ameliorating the adverse impacts of high soybean meal in grouper (Epinephelus coioides);Fish & Shellfish Immunology;2024-10

2. Riding the wave of innovation: immunoinformatics in fish disease control;PeerJ;2023-12-08

3. Alterations of Plasma Biochemical and Immunological Parameters and Spatiotemporal Expression of TLR2 and TLR9 in Gibel Carp (Carassius auratus gibelio) after CyHV-2 Infection;Pathogens;2023-11-08

4. Stress-associated β -glucan administration stimulates the TLR – MYD88 – NFKB1 signaling pathway in Nile tilapia (Oreochromis niloticus);Fish & Shellfish Immunology;2023-11

5. Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy;Viral Immunology;2023-11-01